Cufí, S., Corominas-Faja, B., Vazquez-Martin, A., Oliveras-Ferraros, C., Dorca, J., Bosch-Barrera, J., . . . Menendez, J. A. (2012). Metformin-induced preferential killing of breast cancer initiating CD44(+)CD24(−/low) cells is sufficient to overcome primary resistance to trastuzumab in HER2+ human breast cancer xenografts. Impact Journals LLC.

Cufí, Sílvia, Bruna Corominas-Faja, Alejandro Vazquez-Martin, Cristina Oliveras-Ferraros, Joan Dorca, Joaquim Bosch-Barrera, Begoña Martin-Castillo, und Javier A. Menendez. Metformin-induced Preferential Killing of Breast Cancer Initiating CD44(+)CD24(−/low) Cells Is Sufficient to Overcome Primary Resistance to Trastuzumab in HER2+ Human Breast Cancer Xenografts. Impact Journals LLC, 2012.

Cufí, Sílvia, et al. Metformin-induced Preferential Killing of Breast Cancer Initiating CD44(+)CD24(−/low) Cells Is Sufficient to Overcome Primary Resistance to Trastuzumab in HER2+ Human Breast Cancer Xenografts. Impact Journals LLC, 2012.